Xencor Inc (NAS:XNCR)
$ 25.6 -0.02 (-0.08%) Market Cap: 1.79 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 2.47 GF Score: 63/100

Q2 2021 Xencor Inc Earnings Call Transcript

Aug 04, 2021 / 08:30PM GMT
Release Date Price: $31.06 (-0.96%)
Operator

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to the Second Quarter 2021 Xencor Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

Now I would like to turn the call over to your speaker for today, Charles Liles, Head of Corporate Communications and Investor Relations.

Charles Liles
Xencor, Inc. - Associate Director and Head of Corporate Communications & IR

Thank you, and good afternoon. Earlier today, we issued a press release which outlines the topics we plan to discuss today. It's available at www.xencor.com.

Today on our call, Bassil Dahiyat, President and Chief Executive Officer, will review recent business news and pipeline updates; John Desjarlais, Chief Scientific Officer, will discuss our cytokine and CD28 programs; and John Kuch, Chief Financial Officer, will review financial results. And then we'll open up the call for your questions. And Allen Yang, Chief Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot